Adverse reactions : תופעות לוואי

4.8     Undesirable effects
The most commonly reported undesirable effect was nausea

Frequency of adverse reactions
System Organ Class
Very common                 Common
MedDRA
(≥10%)                      (≥ 1% to <10%)
Nervous system disorders             Headache                       Dizziness Gastrointestinal disorders           Nausea                         Diarrhoea Abdominal pain lower           Vomiting
Reproductive system and              Bleeding not related to        Delay of menses more than breast disorders                     menses*                        7 days ** Menstruation irregular
Breast tenderness
General disorders and                Fatigue administration site conditions
*Bleeding patterns may be temporarily disturbed, but most women will have their next menstrual period within 5-7 days of the expected time.
**If the next menstrual period is more than 5 days overdue, pregnancy should be excluded.

From Post-marketing surveillance additionally, the following adverse events have been reported:

Gastrointestinal disorders
Very rare (<1/10,000): abdominal pain

Skin and subcutaneous tissue disorders
Very rare (<1/10,000): rash, urticaria, pruritus
Reproductive system and breast disorders
Very rare (<1/10,000): pelvic pain, dysmenorrhoea

General disorders and administration site conditions
Very rare (<1/10,000): face oedema

Reporting of suspected adverse reactions
Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.
Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form https://sideeffects.health.gov.il/ 
Side effects can also be reported to the following email: safety@trima.co.il